Evidence map›Paper›PMID 24990966›Full record

ArticleGenes & development2014

Direct control of type IIA topoisomerase activity by a chromosomally encoded regulatory protein.

Seychelle M Vos, Artem Y Lyubimov, David M Hershey, Allyn J Schoeffler, Sugopa Sengupta, Valakunja Nagaraja, James M Berger

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Topoisomerases as anticancer targets.The Biochemical journal · 2018
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Seychelle M VosDepartment of Molecular and Cell Biology.
Artem Y LyubimovDepartment of Molecular and Cell Biology.
David M HersheyDeparment of Plant and Microbial Biology, University of California at Berkeley, Berkeley, California 94720, USA;
Allyn J SchoefflerDepartment of Molecular and Cell Biology.
Sugopa SenguptaDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560 012, India.
Valakunja NagarajaDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560 012, India.
James M BergerDepartment of Molecular and Cell Biology.
Institute of Molecular and Cell Biology · RUIndian Institute of Science Bangalore · INUniversity of California, Berkeley · US

Funding

Structural and Biochemical Analyses of Type II DNA TopoisomerasesR01CA077373 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERGER, JAMES M. · 1999 to 2021
$7.6M
NCI NIH HHS R01 CA077373NCI NIH HHS R01-CA077373
6 · The paper itself

Abstract

Precise control of supercoiling homeostasis is critical to DNA-dependent processes such as gene expression, replication, and damage response. Topoisomerases are central regulators of DNA supercoiling commonly thought to act independently in the recognition and modulation of chromosome superstructure; however, recent evidence has indicated that cells tightly regulate topoisomerase activity to support chromosome dynamics, transcriptional response, and replicative events. How topoisomerase control is executed and linked to the internal status of a cell is poorly understood. To investigate these connections, we determined the structure of Escherichia coli gyrase, a type IIA topoisomerase bound to YacG, a recently identified chromosomally encoded inhibitor protein. Phylogenetic analyses indicate that YacG is frequently associated with coenzyme A (CoA) production enzymes, linking the protein to metabolism and stress. The structure, along with supporting solution studies, shows that YacG represses gyrase by sterically occluding the principal DNA-binding site of the enzyme. Unexpectedly, YacG acts by both engaging two spatially segregated regions associated with small-molecule inhibitor interactions (fluoroquinolone antibiotics and the newly reported antagonist GSK299423) and remodeling the gyrase holoenzyme into an inactive, ATP-trapped configuration. This study establishes a new mechanism for the protein-based control of topoisomerases, an approach that may be used to alter supercoiling levels for responding to changes in cellular state.

Indexed as

Models, MolecularDNA, BacterialDNA GyraseEscherichia coliEscherichia coli ProteinsProtein BindingProtein Structure, QuaternaryDNA, BacterialDNA GyraseEscherichia coli ProteinsYacG protein, E coliDNA topologygyrasemetabolismtranscriptiontype II topoisomeraseYacG

Identifiers

PMID24990966
PMCPMC4083091
OpenAlexW1992269497

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.